Cellectar Biosciences (Warrant)

$0.2176
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.013 (-5.64%) Today
$0.00 (0.00%) As of 10:00 PM UTC after-hours

Why Robinhood?

You can watch CLRBZ and buy or sell other stocks, options, and ETFs commission-free!

About CLRBZ

Cellectar BioSciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma, CLR 125, which intends to treat micro metastatic disease, CLR 124 which could detects tumors and metastases in a broad range of cancers and CLR 1502, a cancer-targeting near-infrared-fluorophore optical imaging PDC for intraoperative tumor and tumor margin illumination.

CEO
James V. Caruso
Employees
—
Headquarters
Florham Park, New Jersey
Founded
1996
Market Cap
—
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
790.25K
High Today
$0.229
Low Today
$0.214
Open Price
$0.229
Volume
155.69K
52 Week High
$1.54
52 Week Low
$0.045

You May Also Like

LGACU
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure